Cite

HARVARD Citation

    Ghia, P. et al. (n.d.). AN ONGOING PHASE 2 STUDY OF IBRUTINIB COMBINED WITH VENETOCLAX IN PATIENTS WITH TREATMENT‐NAÏVE CLL/SLL. Hematological oncology. p. 428. [Online]. 
  
Back to record